Loading
Cases by country, the UK and NHS pathway and other country lenses, the expert centres with trials on record, and the centres named on this cancer's subtypes.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
New York · cancer center | United States | 0 | 5,259 | 96,089 | #1 | ||
Houston · cancer center | United States | 0 | 7,218 | 97,884 | #2 | ||
Villejuif · cancer center | France | none recorded | 0 | 1,878 | 34,575 | #6 | |
Boston · cancer center | United States | 0 | 4,356 | 73,185 | none recorded | #15 | |
Cleveland · hospital | United States | 0 | 2,323 | 28,221 | #20 | ||
Shanghai · hospital | China | none recorded | 0 | 3,733 | 40,855 | - | |
Dallas, TX · cancer center | United States | 0 | 1,628 | 18,297 | - | ||
Philadelphia, PA · cancer center | United States | 0 | 776 | 12,392 | - | ||
Los Angeles, CA · hospital | United States | none recorded | 0 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Chromophobe renal cell carcinoma but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.